(NASDAQ: PDSB) Pds Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Pds Biotechnology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast PDSB's revenue for 2025 to be $34,218,539, with the lowest PDSB revenue forecast at $34,218,539, and the highest PDSB revenue forecast at $34,218,539. On average, 3 Wall Street analysts forecast PDSB's revenue for 2026 to be $378,737,015, with the lowest PDSB revenue forecast at $155,538,815, and the highest PDSB revenue forecast at $699,924,668.
In 2027, PDSB is forecast to generate $1,754,508,941 in revenue, with the lowest revenue forecast at $1,116,893,123 and the highest revenue forecast at $2,706,375,381.